Exact Mass: 423.9655168

Exact Mass Matches: 423.9655168

Found 51 metabolites which its exact mass value is equals to given mass value 423.9655168, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

2-[2-(acetylamino)-4-amino-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole

C15H14BrClN6O2 (424.0050074)

Ambroxol Hydrochloride Impurity B

C14H19Br2ClN2O (423.9552554)

4-(5-Bromo-thiophene-2-sulfonyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester

C14H21BrN2O4S2 (424.01260460000003)

Zinc bis[bis(2-hydroxyethyl)carbamodithioate]

C10H20N2O4S4Zn (423.959733)

Wiskostatin

C17H18Br2N2O (423.9785778)

5-(Bromomethyl)fluorescein

C21H13BrO5 (423.99463080000004)

[5-(trifluoromethylsulfonyloxy)naphthalen-1-yl] trifluoromethanesulfonate

C12H6F6O6S2 (423.9510008)

1,4-Naphthalenebis(trifluoromethanesulfonate)

C12H6F6O6S2 (423.9510008)

Dimethoxy[bis(pentafluorophenyl)]silane

C14H6F10O2Si (423.9977376)

Naphthalene-2,3-diyl bis(trifluoromethanesulfonate)

C12H6F6O6S2 (423.9510008)

Dess-Martin periodinane

C13H13IO8 (423.9655168)

2-Naphthalenecarboxylic acid, 3-hydroxy-4-(4-methyl-3-sulfophenyl)azo-, calcium salt

C18H12CaN2O6S (424.0041962)

Ethaselen

C16H12N2O2Se2 (423.92291520000003)

C471 - Enzyme Inhibitor

(S)-Wiskostatin

C17H18Br2N2O (423.9785778)

Perfluoroadamantane

C10F16 (423.9744512)

4,5-Dihydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonic acid

C16H12N2O8S2 (424.0035072)

(R)-wiskostatin

C17H18Br2N2O (423.9785778)

Adenosine-diphosphate

C10H12N5O10P2-3 (424.0059412)

COVID info from COVID-19 Disease Map, WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

deoxyguanosine diphosphate

C10H12N5O10P2-3 (424.0059412)

8-oxo-dADP

C10H12N5O10P2-3 (424.0059412)

2-oxo-dADP(3-)

C10H12N5O10P2-3 (424.0059412)

N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamide

C18H14ClFN2O3S2 (424.0118376)

ADP(3-)

C10H12N5O10P2 (424.0059412)

A nucleoside 5-diphosphate(3-) arising from deprotonation of all three diphosphate OH groups of adenosine 5-diphosphate (ADP); major species present at pH 7.3.

dGDP(3-)

C10H12N5O10P2 (424.0059412)

A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of dGDP.

8-oxo-dADP(3-)

C10H12N5O10P2 (424.0059412)

An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of 8-oxo-dADP.

KSI-3716

C17H11BrCl2N2O2 (423.93809059999995)

KSI-3716 is a potent c-Myc inhibitor that blocks c-MYC/MAX binding to target gene promoters. KSI-3716 is an effective intravesical chemotherapy agent for bladder cancer[1].

(1r,3r,5s,6e,9s,10s,12r)-9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-ene

C15H19Br2ClO2 (423.9440224)

3-(3,3-dichloro-2-methylpropyl)-1,4-dimethyl-6-(3,3,3-trichloro-2-methylpropyl)piperazine-2,5-dione

C14H21Cl5N2O2 (424.0045596)

9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-7-ene

C15H19Br2ClO2 (423.9440224)

(3s,6s)-3-[(2s)-3,3-dichloro-2-methylpropyl]-1,4-dimethyl-6-[(2s)-3,3,3-trichloro-2-methylpropyl]piperazine-2,5-dione

C14H21Cl5N2O2 (424.0045596)

(2s,3ar,5r,7s,8r,9ar)-2-(3-bromopropa-1,2-dien-1-yl)-5-(1-bromopropyl)-octahydro-2h-furo[3,2-b]oxocine-7,8-diol

C15H22Br2O4 (423.9884732)

(1r,3s,5s,6e,9s,10s,12r)-9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-ene

C15H19Br2ClO2 (423.9440224)

9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-ene

C15H19Br2ClO2 (423.9440224)

(3s)-4,4-dichloro-3-methyl-n-[(1s,3s)-4,4,4-trichloro-3-methyl-1-(1,3-thiazol-2-yl)butyl]butanimidic acid

C13H17Cl5N2OS (423.9504182)

6,7,8,17,18-pentahydroxy-3,10,15,22-tetraoxahexacyclo[14.6.2.0²,¹¹.0⁴,⁹.0¹³,²³.0²⁰,²⁴]tetracosa-1,4,6,8,11,13(23),16(24),17,19-nonaene-14,21-dione

C20H8O11 (424.00666179999996)